ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176327; 2) Community: the network communities that were significantly associated with the response to NSC 176327; 3) Molecule: the relationships between components within communities and NSC 176327; 4) MDR: the compounds that were significantly associated with the NSC 176327.

NSC Compound Enrichment Correlation
NSC 692576 3-Pyridinecarboxylic acid, 2-[[(2-chloro-3-pyridinyl)amino]carbonyl]-1,4-dihydro- 4-(2,4-dimethoxyphenyl)-1-(4-methoxy-2-nitrophenyl)- 6-(4-methylphenyl)-, methyl ester 0.0133299224082802 0.38348212
NSC 719415 Null 0.0133299224082802 0.22746482
NSC 744115 Null 0.0133299224082802 0.45507457
NSC 761822 (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0135714101922724 0.31728417
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0139796580235794 0.057746378
NSC 646140 Null 0.0139796580235794 -0.032715876
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0139796580235794 -0.061191365
NSC 116878 Cardiac glycoside 0.0171439890681608 0.11161744
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0171439890681608 0.21130007
NSC 46401 .alpha.-Sarcin 0.0171439890681608 -0.24362432
Total:41  Current:12    [First] [Prev] [Next] [Last]